Subgroup analyses from one of the agent's pivotal trials showed that 29.5% of adolescents receiving icotrokinra achieved PASI ...

More than 50% of patients with psoriasis are eligible for systemic treatment, and nearly 90% would switch to an effective oral therapy with a favorable safety profile.

Copenhagen University Hospital–Herlev and Gentofte led a nationwide registry study that the authors claim shows a "pattern ...

Childhood emotional trauma significantly elevates psoriasis risk by disrupting immune responses, new research reveals. Early ...

Psoriasis can feel like an uninvited guest that shows up on your skin and refuses to leave. Those red, scaly patches—often ...

Eczema and psoriasis come with similar symptoms and therefore can be easy to confuse. Here's how to differentiate the two.

On World Psoriasis Day 2025, know how stress may spark flare-ups of Psoriasis, why the link matters, and what you can do to ...

Amgen Inc (($AMGN)) announced an update on their ongoing clinical study. Amgen Inc. is conducting a Phase 3 clinical study ...

Icotrokinra demonstrated clinically meaningful outcomes at Week 28 in the Phase 2b ANTHEM-UC study in ulcerative colitis, with 31.7% of patients achieving clinical remission and 38.1% showing endoscop ...

Obesity significantly impacts skin health, leading to common issues like dark patches (acanthosis nigricans) and skin tags ...

The severe stress caused by family upheaval might tax a child's immune system in ways that increase their chances of ...

A recent study published in the journal of Egyptian Rheumatology and Rehabilitation revealed that children with psoriasis are ...